Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Repatha Market Report 2025

Repatha Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Indication (Primary Hypercholesterolemia, Homozygous Familial Hypercholesterolemia (FH), Atherosclerotic Cardiovascular Disease (CVD)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Pediatric, Adult, Geriatric)

Repatha Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Repatha Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Repatha Market Definition

Repatha (evolocumab) is a monoclonal antibody used to lower cholesterol levels in patients with hyperlipidemia. It works by inhibiting PCSK9, a protein that reduces the liver's ability to remove LDL cholesterol from the blood. Repatha is often prescribed for individuals who are unable to achieve desired cholesterol levels through diet or statin therapy alone.

The main indications of repatha are primary hypercholesterolemia, homozygous familial hypercholesterolemia (FH), and atherosclerotic cardiovascular disease (CVD). Primary hypercholesterolemia is a condition of elevated blood cholesterol, primarily due to genetic or lifestyle factors, increasing cardiovascular disease risk. It is distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacies and is used by various end users including pediatric, adult, and geriatric.

Repatha Market Segmentation

The repatha market covered in this report is segmented –

1) By Indication: Primary Hypercholesterolemia; Homozygous Familial Hypercholesterolemia (FH); Atherosclerotic Cardiovascular Disease (CVD)

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

3) By End User: Pediatric; Adult; Geriatric

Repatha Market Size and growth rate 2025 to 2029: Graph

Repatha Market Size 2025 And Growth Rate

The repatha market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rising public awareness about the dangers of high cholesterol, increasing healthcare expenditure, favorable reimbursement policies, increasing use of combination therapies, and growing elderly population.

Repatha Market Growth Forecast

The repatha market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to healthcare shifts towards personalized treatment, expanding healthcare access, rising focus on preventing cardiovascular events, expanding role of telemedicine, and rising investment in cardiovascular research. Major trends in the forecast period include advancements in monoclonal antibody technology, innovations in drug delivery systems, integration with digital health platforms, introduction of combination therapies, and development of long-acting formulations.

Book your 30 minutes free consultation with our research experts

Contact Us

Repatha Market Driver: Rising Prevalence Of Cardiovascular Diseases Driving Growth In The Market

The growing prevalence of cardiovascular diseases is expected to propel the growth of the repatha market going forward. Cardiovascular diseases (CVDs) refer to a group of conditions affecting the heart and blood vessels, including coronary artery disease, heart attacks, strokes, and hypertension. The prevalence of cardiovascular diseases (CVDs) is attributed to factors such as poor diet, lack of physical activity, smoking, excessive alcohol consumption, high blood pressure, and genetic predisposition. Repatha (evolocumab) treats cardiovascular diseases by lowering LDL cholesterol levels, reducing the risk of heart attacks, strokes, and other cardiovascular events in patients with high cholesterol or atherosclerotic cardiovascular disease. For instance, in September 2024, according to the British Heart Foundation, a UK-based cardiovascular research charity, in the UK, approximately 7.6 million individuals are currently affected by heart and circulatory diseases, comprising 4 million men and 3.6 million women. By 2030, this number could increase by 1 million, and by 2040, it may rise to 2 million more than the current figures. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the repatha market.

Repatha Market Driver: Rising Prevalence Of High Cholesterol Fuels Growth In The Market

The rising prevalence of high cholesterol is expected to fuel the growth of the repatha market going forward. High cholesterol refers to elevated levels of low-density lipoprotein (LDL) cholesterol in the blood, which increases the risk of cardiovascular diseases such as heart attacks, strokes, and coronary artery disease. The prevalence of high cholesterol is attributed to factors such as poor diet, lack of physical activity, genetics, obesity, smoking, and excessive alcohol consumption. Repatha (evolocumab) reduces high cholesterol by inhibiting a protein called PCSK9, which increases the liver's ability to remove LDL (bad) cholesterol from the bloodstream. This results in a significant reduction in LDL cholesterol levels. For instance, in December 2023, according to the Australian Bureau of Statistics, an Australian-based government administration, in 2022, approximately 8.4% of people, or 2.1 million individuals, reported having high cholesterol. Therefore, the rising prevalence of high cholesterol is driving the growth of the repatha market.

Repatha Market Driver: Impact Of Rising Obesity Rates On The Growth Of The Market

The rising obesity rate is expected to accelerate the growth of the repatha market going forward. The obesity rate refers to the percentage of individuals in a population who are classified as obese, based on their body mass index (BMI). The rising obesity rate is attributed to factors such as poor dietary habits, increased consumption of processed and high-calorie foods, sedentary lifestyles, lack of physical activity, and genetic predisposition. Repatha is being explored as a potential treatment for obesity by helping to reduce cholesterol levels and improve metabolic health, though its primary use remains in managing hyperlipidemia. For instance, in September 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2022, 22 states recorded an adult obesity rate of 35% or greater, compared to 19 in 2021. Therefore, the rising obesity rate is driving the growth of the repatha market.

Global Repatha Market Major Players

Major companies operating in the repatha market are Amgen Inc.

Regional Analysis For The Global Repatha Market

North America was the largest region in the repatha market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the repatha market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the repatha market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Repatha Market?

The repatha market consists of sales of repatha injections and repatha pre-filled pens. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Repatha Industry?

The repatha market research report is one of a series of new reports from The Business Research Company that provides repatha market statistics, including the repatha industry global market size, regional shares, competitors with the repatha market share, detailed repatha market segments, market trends, and opportunities, and any further data you may need to thrive in the repatha industry. This repatha market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

    Table Of Contents

    1. Executive Summary

    2. Repatha Market Characteristics

    3. Repatha Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Repatha Market Trends And Strategies

    5. Repatha Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Repatha Growth Analysis And Strategic Analysis Framework

    6.1. Global Repatha PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Repatha Market Growth Rate Analysis

    6.4. Global Repatha Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Repatha Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Repatha Total Addressable Market (TAM)

    7. Global Repatha Pricing Analysis & Forecasts

    8. Repatha Market Segmentation

    8.1. Global Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Primary Hypercholesterolemia

    Homozygous Familial Hypercholesterolemia (FH)

    Atherosclerotic Cardiovascular Disease (CVD)

    8.2. Global Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    8.3. Global Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Pediatric

    Adult

    Geriatric

    9. Global Repatha Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Repatha Market Regional And Country Analysis

    10.1. Global Repatha Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Repatha Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Repatha Market

    11.1. Asia-Pacific Repatha Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Repatha Market

    12.1. China Repatha Market Overview

    12.2. China Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Repatha Market

    13.1. India Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Repatha Market

    14.1. Japan Repatha Market Overview

    14.2. Japan Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Repatha Market

    15.1. Australia Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Repatha Market

    16.1. South Korea Repatha Market Overview

    16.2. South Korea Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Repatha Market

    17.1. Western Europe Repatha Market Overview

    17.2. Western Europe Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Repatha Market

    18.1. UK Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Repatha Market

    19.1. Germany Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Repatha Market

    20.1. France Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Repatha Market

    21.1. Eastern Europe Repatha Market Overview

    21.2. Eastern Europe Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Repatha Market

    22.1. North America Repatha Market Overview

    22.2. North America Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Repatha Market

    23.1. USA Repatha Market Overview

    23.2. USA Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Repatha Market

    24.1. Canada Repatha Market Overview

    24.2. Canada Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Repatha Market

    25.1. South America Repatha Market Overview

    25.2. South America Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Repatha Market

    26.1. Middle East Repatha Market Overview

    26.2. Middle East Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Repatha Market

    27.1. Africa Repatha Market Overview

    27.2. Africa Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Repatha Market Competitive Landscape And Company Profiles

    28.1. Repatha Market Competitive Landscape

    28.2. Repatha Market Company Profiles

    28.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Repatha Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Repatha Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Repatha Market

    32. Recent Developments In The Repatha Market

    33. Repatha Market High Potential Countries, Segments and Strategies

    33.1 Repatha Market In 2029 - Countries Offering Most New Opportunities

    33.2 Repatha Market In 2029 - Segments Offering Most New Opportunities

    33.3 Repatha Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Repatha Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Repatha Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Amgen Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Repatha Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Repatha Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Repatha Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Repatha Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Repatha Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Amgen Inc. Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

Global Cancer Immunotherapy Market Overview And Prospects – Includes Cancer Immunotherapy Market Share

Read More

How Will The Biosimilar Interleukins Market Grow In 2022?

Read More

Latest Cancer Clinical Decision Tools Market Growth Study 2022-2026 By The Business Research Company

Read More

Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the high potency apis market research report 2022 with industry size, share, segments and market growth

Read More

Travel Insurance Market 2023 – By Type (Domestic, International), By Insurance Cover (Single-Trip Travel Insurance, Annual Multi-Trip Travel Insurance, Long-Stay Travel Insurance), By Distribution Channel (Insurance Intermediaries, Insurance Companies, Banks, Other Distribution Channels), By Coverage (Medical Expenses, Trip Cancellation, Trip Delay, Property Damage, Other Coverages), By End-User (Senior Citizens, Corporate Travelers, Family Travelers, Education Travelers, Other End-Users), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Wire-to-Board Connector Global Market Report 2025 – By Type (Below 1.00 MM, 1.00 MM to 2.00 MM, Above 2.00 MM), By Style (Accessory, Header, Housing, Plug, Receptacle, Socket), By Application (Transportation, Consumer Electronics, Communications, Industries, Military, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Inorganic Catalyst Global Market Report 2025 – By Type (Zeolites, Metals, Chemical Compounds, Other Types), By Process (Recycling, Regeneration, Rejuvenation), By Applications (Petroleum Refining, Chemical Synthesis, Polymers And Petrochemicals, Environmental ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Boom Lifts Global Market Report 2025 – By Type (Articulating Boom Lifts, Telescopic Boom Lifts, Straight Boom Lifts, Genie Boom lifts, Towable Boom Lifts), By Movement Type (Mobile, Fixed), By Engine Type (Electric, Engine Powered), By End User (Rental, Construction And Building, Mining, Transportation And Logistics, Landscaping And Orchard Work, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Secondary School Global Market Report 2025 – By Type Of Expenditure (Public, Private), By Ownership (Government, Local Body, Others), By Fee Structure (Low-Income, Medium-Income, High-Income) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Transport Media Global Market Report 2025 – By Product (Viral Transport Media, Universal Transport Media, Molecular Transport Media, Other Products), By Indication (Viral Diseases, Non- Viral Diseases), By Application (Diagnosis, Preclinical Testing), By End User (Hospitals, Clinics, Microbiology laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hospital Daily Cash Benefit Insurance Market 2023 – By Type of Plan (Rider, Standalone Cover, Part of Health Insurance), By Benefit (Emergency Admission, Accident, Medical Treatment, Surgery), By Service Provider (Public, Private), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Frequently Asked Questions

What is the definition of the Repatha market?

Repatha (evolocumab) is a monoclonal antibody used to lower cholesterol levels in patients with hyperlipidemia. It works by inhibiting PCSK9, a protein that reduces the liver's ability to remove LDL cholesterol from the blood. Repatha is often prescribed for individuals who are unable to achieve desired cholesterol levels through diet or statin therapy alone. For further insights on the Repatha market, request a sample here

How will the Repatha market drivers and restraints affect the market dynamics? What forces will shape the Repatha industry going forward?

The Repatha market major growth driver - Rising Prevalence Of Cardiovascular Diseases Driving Growth In The Market. For further insights on the Repatha market, request a sample here

What is the forecast market size or the forecast market value of the Repatha market?

The Repatha market size has grown strongly in recent years. The repatha market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rising public awareness about the dangers of high cholesterol, increasing healthcare expenditure, favorable reimbursement policies, increasing use of combination therapies, and growing elderly population. The repatha market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to healthcare shifts towards personalized treatment, expanding healthcare access, rising focus on preventing cardiovascular events, expanding role of telemedicine, and rising investment in cardiovascular research. Major trends in the forecast period include advancements in monoclonal antibody technology, innovations in drug delivery systems, integration with digital health platforms, introduction of combination therapies, and development of long-acting formulations. For further insights on the Repatha market, request a sample here

How is the Repatha market segmented?

The repatha market covered in this report is segmented –
1) By Indication: Primary Hypercholesterolemia; Homozygous Familial Hypercholesterolemia (FH); Atherosclerotic Cardiovascular Disease (CVD)
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By End User: Pediatric; Adult; Geriatric For further insights on the Repatha market, request a sample here

Which region has the largest share of the Repatha market? What are the other regions covered in the report?

North America was the largest region in the repatha market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the repatha market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Repatha market, request a sample here.

Who are the major players in the Repatha market?

Major companies operating in the repatha market are Amgen Inc. . For further insights on the Repatha market, request a sample here.

What are the key trends in the Repatha market?

Major trends in the Repatha market include . For further insights on the Repatha market, request a sample here.

What are the major opportunities in the Repatha market? What are the strategies for the Repatha market?

For detailed insights on the major opportunities and strategies in the Repatha market, request a sample here.

How does the Repatha market relate to the overall economy and other similar markets?

For detailed insights on Repatha's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Repatha industry?

For detailed insights on the mergers and acquisitions in the Repatha industry, request a sample here.

What are the key dynamics influencing the Repatha market growth? SWOT analysis of the Repatha market.

For detailed insights on the key dynamics influencing the Repatha market growth and SWOT analysis of the Repatha industry, request a sample here.